Imbruvica 140 MG capsule 120S
Ended Awarded Last action
- Contract number
- SPE2DR26F9P4P
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,405
Award facts
- Contract value 100% obligated
- $11,405.25 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,405.25 to AmerisourceBergen Drug Corp for the supply of Imbruvica 140 mg capsules (120-count units) on November 28, 2025. This is a firm fixed price, non-set-aside contract with a completion date of December 19, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania will serve as the place of performance. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999 and extends through December 2026. This comprehensive prime vendor agreement enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical federal vendor that supplies medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains to military and veteran healthcare systems. The company has demonstrated capability to meet federal procurement requirements through competitive awards with the Defense Logistics Agency and other government healthcare organizations, including the Defense Health Agency and U.S. Coast Guard. Imbruvica is a specialty pharmaceutical product used in oncology treatment, consistent with AmerisourceBergen's portfolio of brand-name and generic medications supporting federal medical supply needs.
Quick answers
Who was awarded contract SPE2DR26F9P4P?
SPE2DR26F9P4P was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 28, 2025.
How much is contract SPE2DR26F9P4P worth?
The government has obligated $11,405 on SPE2DR26F9P4P.
Is contract SPE2DR26F9P4P an order under another contract?
Yes. SPE2DR26F9P4P is a delivery order under SPE2DR25D3020, an indefinite delivery contract.
Was contract SPE2DR26F9P4P competed?
The extent of competition for SPE2DR26F9P4P was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award